The performance of companies tied to the drug's history presents a intricate investment scenario . While the initial boom generated substantial profits , generic alternatives have significantly eroded https://sociallweb.com/story7184533/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-risky-venture